Denali Therapeutics

DNLI

DNLI Denali Therapeutics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    DNLI Chart
    See on advanced chart >

    About

    Denali Therapeutics Inc. was incorporated in Delaware in October 2013. Their goal is to discover and develop therapeutics to defeat degeneration.Neurodegeneration represents one of the most significant unmet medical needs of their time, with few effective...
    • Highlight
      A biopharmaceutical company that develops a broad portfolio of product candidates engineered to cross the blood-brain barrier for neurodegenerative diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      12/08/2017
    • Established Date
      Invalid Date
    • Full-time Employees
      445
    • Address
      161 Oyster Point Blvd South San Francisco CA 94080
    • Tel
      1-650-8668548
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-03-02 05:34:52